The largest database of trusted experimental protocols

4 protocols using anti cd8 sk1

1

Single-Cell Sorting of Tumor-Infiltrating T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
T cells were isolated from tumor single cell suspensions by antibody staining followed by cell sorting on a 5-laser FACSAria Fusion sorter (Stanford FACS Facility) purchased using funds from the Parker Institute for Cancer Immunotherapy. Tumor cell suspensions were stained in PBS with Zombie Aqua dye (Biolegend) for viability assessment. This was followed by staining in PBS with 2% FBS in Fc Blocking solution (Biolegend) plus the following antibodies: anti-CD4 (OKT4, Biolegend), anti-CD8 (SK1, Biolegend), anti-CD3 (OKT3, Biolegend), anti-CD45 (H130, Biolegend), anti-CD25 (BC96, Biolegend), anti-PD-1(EH12.2H7, Biolegend), anti-CD137 (4B4-1, BD Biosciences), anti-HLA-DR (L243, Biolegend). CD3+CD45+AquaZombie- cells were index sorted directly into 96-well plates preloaded with 4 uL of capture buffer, snap frozen on dry ice, and stored at −80°C. Ectopic HLA-B35 was detected with anti-HLA-BC monoclonal antibody (clone B1.23.2, Thermo Fisher Scientific). Transduced Jurkat 76 cells expressing exogenous TCRα/β chains were sorted on a FACSAria Fusion sorter at Stanford or a BD Biosciences Influx High Speed Cell Sorter at the Flow Cytometry Core Facility of the Cancer Institute of New Jersey.
+ Open protocol
+ Expand
2

Flow Cytometry and Functional Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following antibodies were used for flow cytometric analysis: anti-TCR (clone IP26; BioLegend), anti-CD3 (OKT3; BioLegend), anti-vβ3.1 [JOVI.3; Becton, Dickinson & Company (BD)], anti-CD4 (OKT4; BioLegend), anti-CD8 (SK1; BioLegend), HLA-A2 (BB7.2; BioLegend), and HLA-DR (L243; BioLegend). Isotype-matched control antibodies were used in all cases.
For functional reporter assays, blinatumomab was obtained from Myonex; staphylococcal enterotoxin E was obtained from Toxin Technology Inc.; recombinant H3 was obtained from Sino Biological; 2020 Fluzone Quadrivalent (NDC 49281-420-88) was obtained from Sanofi Pasteu.
Antigenic peptides [MART-126–35, MART-127–35, MART-1Leu26–35, hemagglutinin (HA)307–319, and associated HA peptides from H3, H1, and H5] were custom synthesized at >95% purity by Vivitide, and lyophilized peptides were then reconstituted in dimethyl sulfoxide (Sigma-Aldrich) or ddH20, and stored at −80°C.
+ Open protocol
+ Expand
3

WNK3 Knockdown in T Cell Subsets

Check if the same lab product or an alternative is used in the 5 most similar protocols
For WNK3 knockdown in human CD4+ and CD8+ T cells, live CD4+ and CD8+ T cells were sorted from human PBMCs using an MA900 sorter (SONY, San Jose, CA, USA) and stimulated with plate-bound anti-human CD3 (#BE0001-2, BioXCell, Lebanon, NH, USA)/anti-human CD28 (#BE0248, BioXCell) and 50 IU IL-2 for 24 h. These cells were spin-infected (900 × g, 90 min, 37 °C) with lentiviral supernatant (shNC and shWNK3). Four days after lentiviral infection, cells were selected with 1 μg/ml puromycin for 7 days. Then, the cells were stimulated with Dynabeads Human T-Activator CD3/CD28 (Gibco) for 36 h. BD GolgiStop (#554724, BD Biosciences) was added for the last 6 h of stimulation. After stimulation, the cells were washed, and surface molecules were stained with anti-CD4 (OKT4, BioLegend) and anti-CD8 (SK1, BioLegend). Cells were then fixed with eBioscience/Invitrogen Intracellular (IC) Fixation Buffer (#00-8222-49, Invitrogen), washed with 1x Permeabilization Buffer (#00-8333-56, Invitrogen) and stained with antibodies for anti-perforin (B-D48, BioLegend) and anti-granzyme B (QA16A02, BioLegend).
+ Open protocol
+ Expand
4

Multiparametric Flow Cytometry Immune Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMCs were isolated using Ficoll-Paque density gradient centrifugation, frozen in freezing medium [10% DMSO, 90% fetal bovine serum (FBS)] and stored at -80°C until use. For staining, PBMCs were thawed using complete RPMI (RPMI+10%FBS) and washed with PBS. The cells were first stained using Fixable Aqua Dead Cell Kit (Thermofisher), followed by staining with anti-CD3 (UCHT1) (Biolegend), anti-CD4 (RPA-T4) (BD Biosciences), anti-CD8 (SK1) (Biolegend), anti-CD19 (HIB19) (BD Biosciences), anti-CD27 (O323) (Biolegend), anti-CD56 (B159) (BD Biosciences), anti-CD45RA (2H4) (Beckman Coulter), anti-CD38 (HIT2) (BD Biosciences) and anti-CD38 (JK36) (Beckman Coulter). The cells were washed and analyzed using BD LSRFortessa™ cell analyzer. Data analyses were performed using Flowjo V10.5.3 (BD)
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!